Grattan Institute under fire for ‘inflated’ PBS savings claim

The Grattan Institute is receiving criticism from a range of health bodies after admitting the use of inaccurate figures in calculating PBS savings.

Following on from this admission, Medicines Australia has raised doubts that benchmarking instead of co-payment changes would be the best outcome for the government and consumers.

In an appearance before a Senate hearing earlier this week, the Grattan Institute acknowledged that their proposed annual savings from benchmarking 20 commonly-used drugs against UK prices was